Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

Clinical trial NCT02445612 · COMPLETED

Trial details

NCT number: NCT02445612
Sponsor: Astellas Institute for Regenerative Medicine
Status: COMPLETED
Study type: OBSERVATIONAL

Stargardt's Macular Dystrophy

Start date: 2012-07-11
Primary completion: 2019-06-21
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.